Washington: Australian diagnostics company Ellume has won approval from US regulators to sell the first rapid at-home COVID-19 tests that don’t require a prescription.
The Brisbane-based company was granted an emergency use authorisation on Wednesday (AEDT) by the US Food and Drug Administration (FDA) to sell its over-the-counter tests.
Stephen Hahn, the head of the FDA, hailed the authorisation as “a major milestone in diagnostic testing for COVID-19”.
Alongside vaccinations, health experts believe rapid at-home testing will provide a crucial tool to bring the pandemic under control. Read more…..
Chart of the Day
Yahoo Finance’s Dr. Dara Kass reports on the latest news on Remdesivir, Southwest Airlines booking more passengers, the presidential debate, vaccine distribution, mask wearing, students returning to school, and more.